Anthony Krick - OptiNose VP Officer

0OP Stock  EUR 0.38  0.01  2.70%   

Insider

Anthony Krick is VP Officer of OptiNose
Phone267 364 3500
Webhttps://www.optinose.com

Anthony Krick Latest Insider Activity

Tracking and analyzing the buying and selling activities of Anthony Krick against OptiNose stock is an integral part of due diligence when investing in OptiNose. Anthony Krick insider activity provides valuable insight into whether OptiNose is net buyers or sellers over its current business cycle. Note, OptiNose insiders must abide by specific rules, including filing SEC forms every time they buy or sell OptiNose'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.

OptiNose Management Efficiency

The company has return on total asset (ROA) of (0.312) % which means that it has lost $0.312 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (10.505) %, meaning that it generated substantial loss on money invested by shareholders. OptiNose's management efficiency ratios could be used to measure how well OptiNose manages its routine affairs as well as how well it operates its assets and liabilities.
OptiNose has accumulated 126.42 M in total debt. OptiNose has a current ratio of 2.77, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist OptiNose until it has trouble settling it off, either with new capital or with free cash flow. So, OptiNose's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like OptiNose sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for OptiNose to invest in growth at high rates of return. When we think about OptiNose's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Manfred MuellerIdentiv
53
Aaron SchachtElanco Animal Health
51
Rick CarronSuperior Plus Corp
N/A
Steve DunlapIdentiv
N/A
Robert GreenSIVERS SEMICONDUCTORS AB
60
Torsten LeueTalanx AG
57
Denise ScotsKnightElanco Animal Health
59
Arvid MossNorsk Hydro ASA
65
John BilbreyElanco Animal Health
63
Sven PetterssonSIVERS SEMICONDUCTORS AB
60
Kapila AnandElanco Animal Health
65
Joshua SmileyElanco Animal Health
49
Ramiro CabralElanco Animal Health
51
Carl McMillianElanco Animal Health
51
Hilde NordhNorsk Hydro ASA
54
David UrbanekElanco Animal Health
56
Michael HarringtonElanco Animal Health
56
Steven HumphreysIdentiv
62
David BullockOrigin Agritech
49
Leigh DowIdentiv
N/A
Mohammad YousafNMI Holdings
47
OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. OptiNose, Inc. was founded in 2000 and is headquartered in Yardley, Pennsylvania. OPTINOSE INC operates under Drug ManufacturersSpecialty Generic classification in Germany and is traded on Frankfurt Stock Exchange. It employs 204 people. OptiNose (0OP) is traded on Frankfurt Exchange in Germany and employs 189 people.

Management Performance

OptiNose Leadership Team

Elected by the shareholders, the OptiNose's board of directors comprises two types of representatives: OptiNose inside directors who are chosen from within the company, and outside directors, selected externally and held independent of OptiNose. The board's role is to monitor OptiNose's management team and ensure that shareholders' interests are well served. OptiNose's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, OptiNose's outside directors are responsible for providing unbiased perspectives on the board's policies.
Sandra Helton, Independent Director
Tomas Heyman, Director
Anthony Krick, VP Officer
Ramy Mahmoud, President, Chief Operating Officer
John Messina, Sr Affairs
Catherine Owen, Director
Jonathan Neely, VP Operations
Joshua Tamaroff, Independent Director
Joseph Scodari, Independent Chairman of the Board
Keith Goldan, Chief Financial Officer
Sriram Venkataraman, Independent Director
Wilhelmus Groenhuysen, Independent Director
Peter Miller, Chief Executive Officer, Director
Michele MBA, VP CFO
Robert ONeil, Independent Director
Karen Brophy, Chief HR
William Doyle, Independent Director
Michael Esq, Chief Sec
Victor Clavelli, Chief Commercial Officer
Per MD, CoFounder AS
Michael Marino, Chief Legal Officer and Corporate Secretary
MPH MD, Pres COO

OptiNose Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is OptiNose a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Currently Active Assets on Macroaxis

Additional Information and Resources on Investing in OptiNose Stock

When determining whether OptiNose offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of OptiNose's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Optinose Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Optinose Stock:
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Please note, there is a significant difference between OptiNose's value and its price as these two are different measures arrived at by different means. Investors typically determine if OptiNose is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, OptiNose's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.